A detailed safety assessment of a saw palmetto extract
- 30 June 2008
- journal article
- research article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 16 (3) , 147-154
- https://doi.org/10.1016/j.ctim.2007.10.005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hepatotoxicity potential of Saw Palmetto (Serenoa repens) in ratsPhytomedicine, 2007
- Saw palmetto and lower urinary tract symptoms: What is the latest evidence?Current Urology Reports, 2006
- Saw Palmetto-induced PancreatitisSouthern Medical Journal, 2006
- Saw Palmetto for Benign Prostatic HyperplasiaNew England Journal of Medicine, 2006
- Disclosure of Natural Product Use to Primary Care Physicians: A Cross-sectional Survey of Naturopathic Clinic AttendeesMayo Clinic Proceedings, 2005
- Serenoa repens (Permixon®) inhibits the 5α‐reductase activity of human prostate cancer cell lines without interfering with PSA expressionInternational Journal of Cancer, 2004
- Phytotherapy in the treatment of benign prostatic hyperplasiaCurrent Opinion in Urology, 2002
- Phytotherapy for benign prostatic hyperplasiaPublic Health Nutrition, 2000
- Use of alternative health care by family practice patientsArchives of Family Medicine, 1997
- A brief male sexual function inventory for urologyUrology, 1995